Linamarin‐loaded poly (lactide‐co‐glycolide) (PLGA) nanoparticles (NPs) were prepared by the double emulsion solvent evaporation technique. The formulated PLGA (50:50) and PLGA (85:15) NPs were spherically shaped, having an average particle size < 190 nm, drug entrapment efficiency (50–52%) and zeta potentials ranging from −25 to −30 mV. Interestingly, all formulated PLGA NPs exhibited a controlled biphasic release profile. Polymer degradation was investigated in the current research to determine the major degradation products and then the polymer biocompatibility as well as safety. The PLGA NPs degradation behaviour was investigated by measuring water uptake, mass loss, change of pH of the degradation medium, morphological changes, and lactic and glycolic acid concentrations. Gravimetrical methods, pH meter, scanning electron microscope and high‐performance liquid chromatography were employed, respectively. PLGA (50:50) NPs were found to degrade faster than PLGA (85:15) NPs. With regard to water uptake, mass loss and pH change, the degradation behaviour of PLGA (50:50) NPs was significantly ( ρ < 0.05) different from that of PLGA (85:15) NPs. A complete degradation of PLGA (50:50) NPs was achieved after 102 days, whereas, only about 60% of PLGA (85:15) NPs were degraded within the same period. Complete degradation and release of the degradation products naturally by the body ensures safety of the delivery carrier.
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with linamarin as a model drug were successfully prepared using the double emulsion solvent evaporation technique. The physicochemical characterization of the formulated nanoparticles revealed that they were spherical, nonaggregated, and negatively charged, with good drug encapsulation efficiencies (>50%) and average particle sizes <200 nm. Interestingly, all the nanoparticles exhibited dibasic release profiles with a starting burst release within the first 8 h, followed by a controlled release phase lasting four days. Thus, linamarin-loaded nanoparticles indicate a promising candidate for controlled drug release applications.
1 January 2012 in International Journal of Nanoparticles
Development of a successful delivery system capable of delivering an active agent to its targeted site at right concentration and time remains a challenge especially in the field of pharmaceutics where most drugs lack specificity and some side effects may exist. In the last few years, the recent advances in the field of nanotechnology led to the generation of promising particulate polymeric delivery systems. Among these systems biodegradable micro and nanoparticles are the most extensively investigated ones. They proved to be capable of improving the drug administration, efficacy and safety compared to conventional therapeutics. The present review highlights the various aspects of development, preparation methods and advantages of the biodegradable particulate delivery systems. More focus will be on poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and poly(lactide-co-glycolide acid) (PLGA)-based delivery systems.